SecSonar.com

Harmony Biosciences Holdings, Inc. (HRMY)

Harmony Biosciences Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Harmony Biosciences Holdings, Inc. (HRMY) is a Biotechnology company based in US with a market capitalization of $1.8B. Revenue grew 21.5% year-over-year and the company generated $347.9M in free cash flow. This page tracks HRMY's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 268 employees · IPO Aug 19, 2020

Valuation

Valuation & price

$30.09 · as of May 17, 2026 · -25.7% vs 52w high

11.1

P/E ratio

Latest-FY diluted EPS

2.11

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$40.51$33.23$25.95Jul 25Dec 25Jul 26Jul 7, 25$32.24Jul 9, 25$34.29Jul 11, 25$34.00Jul 15, 25$34.84Jul 17, 25$36.43Jul 21, 25$35.25Jul 23, 25$37.22Jul 25, 25$37.52Jul 29, 25$35.45Jul 31, 25$35.18Aug 4, 25$35.54Aug 6, 25$34.67Aug 11, 25$34.80Aug 13, 25$36.67Aug 15, 25$36.87Aug 19, 25$36.40Aug 21, 25$37.29Aug 25, 25$37.42Aug 27, 25$38.05Aug 29, 25$36.89Sep 3, 25$37.53Sep 5, 25$35.99Sep 9, 25$34.00Sep 11, 25$33.42Sep 16, 25$32.29Sep 18, 25$32.63Sep 22, 25$32.42Sep 24, 25$26.76Sep 26, 25$27.51Sep 30, 25$27.56Oct 2, 25$26.76Oct 6, 25$26.59Oct 8, 25$26.56Oct 10, 25$26.54Oct 14, 25$26.84Oct 16, 25$25.95Oct 21, 25$26.16Oct 23, 25$29.60Oct 27, 25$30.11Oct 29, 25$29.32Oct 31, 25$28.57Nov 4, 25$30.72Nov 6, 25$30.94Nov 10, 25$31.82Nov 12, 25$33.54Nov 14, 25$34.03Nov 18, 25$33.99Nov 20, 25$33.39Nov 25, 25$35.34Nov 28, 25$35.29Dec 2, 25$36.01Dec 4, 25$38.25Dec 8, 25$38.92Dec 10, 25$39.27Dec 12, 25$40.51Dec 16, 25$38.83Dec 18, 25$37.47Dec 22, 25$38.86Dec 24, 25$38.49Dec 29, 25$37.91Jan 2, 26$37.38Jan 6, 26$36.75Jan 8, 26$37.87Jan 12, 26$38.27Jan 14, 26$36.04Jan 16, 26$36.22Jan 21, 26$36.69Jan 23, 26$36.82Jan 27, 26$37.68Jan 29, 26$36.86Feb 2, 26$37.84Feb 4, 26$37.32Feb 9, 26$37.08Feb 11, 26$36.59Feb 13, 26$36.01Feb 18, 26$35.28Feb 20, 26$29.16Feb 24, 26$28.19Feb 26, 26$29.05Mar 2, 26$28.90Mar 4, 26$28.54Mar 6, 26$28.33Mar 10, 26$28.74Mar 12, 26$27.79Mar 17, 26$28.37Mar 19, 26$27.81Mar 23, 26$27.60Mar 25, 26$27.59Mar 27, 26$26.54Mar 31, 26$28.01Apr 2, 26$27.74Apr 7, 26$27.62Apr 9, 26$29.16Apr 13, 26$29.05Apr 15, 26$29.22Apr 17, 26$29.99Apr 22, 26$31.97Apr 24, 26$30.80Apr 28, 26$31.16Apr 30, 26$31.26May 4, 26$32.59May 6, 26$32.78May 8, 26$30.99May 12, 26$30.15May 14, 26$30.76May 18, 26$29.83May 20, 26$31.38May 22, 26$30.15May 28, 26$31.49Jun 1, 26$31.81Jun 3, 26$32.10Jun 5, 26$32.20Jun 9, 26$34.10Jun 11, 26$35.20Jun 15, 26$34.18Jun 17, 26$33.77Jun 22, 26$33.43Jun 24, 26$34.45Jun 26, 26$35.47Jul 2, 26$36.54
$25.9052-week range$40.51
Loading valuation history…

Fundamentals

Key fundamentals

$1.8B

Market cap

21.5%

Revenue growth (YoY)

77.2%

Gross margin

$347.9M

Free cash flow (USD)

-$535.8M

Net debt

Net cash position

1.1%

Share dilution

4/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$0.00FY 2019$6.0MFY 2020$159.7MFY 2021$305.4MFY 2022$437.9MFY 2023$582.0MFY 2024$714.7MFY 2025$868.5M
$0$868.5M

Free cash flow by year

2018 → 2025

FY 2018$-40.1MFY 2019$-75.6MFY 2020$-5.0MFY 2021$98.3MFY 2022$144.3MFY 2023$219.1MFY 2024$218.7MFY 2025$347.9M
-$40.1M$347.9M

Gross margin by year

2021 → 2025

FY 202181.8%FY 202280.9%FY 202379.2%FY 202478.1%FY 202577.2%
81.8%77.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • 8-K eventCFO Separation AgreementApr 14, 2026Filing
  • 8-K eventExecutive Employment AgreementApr 2, 2026Filing

Questions

Frequently asked questions

What is Harmony Biosciences Holdings, Inc.'s market cap?

Harmony Biosciences Holdings, Inc. (HRMY) has a market capitalization of $1.8B.

What is HRMY's P/E ratio?

HRMY trades at a price-to-earnings ratio of 11.1, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is HRMY's price-to-book (P/B) ratio?

HRMY trades at 2.11 times book value per share.

Are insiders buying HRMY stock?

SEC Form 4 filings show no open-market insider buys at Harmony Biosciences Holdings, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ZYME

Zymeworks Inc.

$1.9B

AAPG

Ascentage Pharma Group International

$1.9B

NVAX

Novavax, Inc.

$1.8B

BCRX

BioCryst Pharmaceuticals, Inc.

$1.9B

GLPG

Galapagos N.V.

$1.9B

ABCL

AbCellera Biologics Inc.

$1.9B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.